Home Novo Nordisk buys rights to Caisson's drug-extending biotech
 

Keywords :   


Novo Nordisk buys rights to Caisson's drug-extending biotech

2014-03-18 23:01:17| Biotech - Topix.net

HEPtune, which conjugates the polymer heparosan to a drug to prolong its half-life, will be licensed to Novo Nordisk exclusively for insulin products, and non-exclusively for delivery of other therapies including human growth hormones and treatments for obesity and inflammatory diseases.

Tags: rights novo biotech buys

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.10'Rightmove is my porn' - the addiction to online property search
06.10Eastern North Pacific Tropical Weather Outlook
06.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Public Advisory Number 2
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 26
05.10Tropical Storm Milton Graphics
05.10Hurricane Kirk Wind Speed Probabilities Number 26
More »